As far as aspirations go, QuantuMDx is setting its sights high. The UK diagnostics start-up is still in the early stages of product development but one thing CEO Elaine Warburton has set her mind on is ensuring the company’s “lab-in-your-hand” device will emulate the sleek, simple and user-friendly designs that are iconic of the information technology giant Apple.

The UK-based company is seeking to raise a further $100m in 2021 following the recent US clearance of its first product, a daytime-use neurostimulation device for snoring and mild obstructive sleep apnea.

The deal combines two of the largest providers of sterilization and infection-prevention products to create a $4bn-plus-revenue business.